In breast cancer, increased apelin levels were found to be an independent predictor of HER-2/neu expression and breast cancer phenotype, which accounts for 30% of breast carcinomas and is associated with a more aggressive tumor behavior [228]. This evidence concerns the gene ERBB2 and breast cancer.